John P. Brancaccio
CIK: 0001276551
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
OKYO
OKYO Pharma Ltd
Director
Discretionary Trading P&L
Holdings
About BRANCACCIO JOHN P
BRANCACCIO JOHN P (SEC CIK 0001276551) files insider reports with the SEC as Director of OKYO Pharma Ltd (OKYO).
Signal8 holds 4 ownership filings by BRANCACCIO JOHN P (1 Form 3, 3 Form 4), filed between Jun 1, 2026 and Aug 7, 2026. Those filings report 3 transactions, from Jun 8, 2026 to Jul 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on BRANCACCIO JOHN P's filings is in LONDON.
Recent filings by BRANCACCIO JOHN P
Other insiders filing for OKYO Pharma Ltd (OKYO)
- Dempsey Robert John, CHIEF EXECUTIVE OFFICER
- JACOB GARY S, CHIEF DEVELOPMENT OFFICER
- CERRONE GABRIELE M, Director
- Mantelli Flavio, CHIEF MEDICAL OFFICER
- Patil Rajkumar V., Chief Scientific Officer
- Denoyer Bernard, Director